Page 15 - Success Story

BIRAC Success Stories | 2016 Biological E

Key Highlights

* Launched in Year 2011 after obtaining
Breakthrough all approvals under the trade name
JEEV.
• Developed JEEV, first indigenous, * cGMP facilities with a capacity of 10
cost effective and second generation million doses established.
vaccine against JE. * Launched in the Indian private market
• JEEV is inactivated JE vaccine based in 2012. Almost 5 Lac doses distributed.
on SA 14-14-2 strain and produced on * Secured WHO PQ approval. JEEV has
vero cells without any preservatives. already received marketing approval
• Manufacturing commenced in Year in 2 countries. Other registrations in
2011. process.
• JEEV was the first JE vaccine globally * Employment to ~250 professionals.
to receive WHO pre-qualification
approval in 2013.
• Envisaging introduction of inactivated
JE vaccines in the National
Immunization Program.

BIRAC’s Support

Phase III clinical study of JE vaccine has
been funded under the BIPP program
to the extent of INR 5.73 crores. This
played a critical role in successful
completion of the Phase III study and
securing approvals from India NRA.

15